Thunder Bridge Capital Partners III (TBCP) 10-Q14 Nov 232023 Q3 Quarterly reportFinancial data

Company Profile

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2023	Nov. 14, 2023
Document Information Line Items
Entity Registrant Name	THUNDER BRIDGE CAPITAL PARTNERS III, INC.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001815753
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-39998
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-1445798
Entity Address, Address Line One	9912 Georgetown Pike
Entity Address, Address Line Two	Suite D203
Entity Address, City or Town	Great Falls
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22066
City Area Code	(202)
Local Phone Number	431-0507
Entity Interactive Data Current	Yes
Units, each consisting of one share of Class A common stock and one-fifth of one redeemable Warrant
Document Information Line Items
Trading Symbol	TBCPU
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-fifth of one redeemable Warrant
Security Exchange Name	NASDAQ
Class A common stock, par value $0.0001 per share
Document Information Line Items
Trading Symbol	TBCP
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Security Exchange Name	NASDAQ
Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
Document Information Line Items
Trading Symbol	TBCPW
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
Security Exchange Name	NASDAQ
Class A Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		11,964,156
Class B Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		1

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 30,377	$ 180,109
Prepaid expenses	40,142	30,013
Prepaid income taxes	15,273
Total current assets	85,792	210,122
Other assets:
Cash and marketable securities held in Trust Account	6,306,990	12,263,483
Total assets	6,392,782	12,473,605
Current liabilities:
Accounts payable and accrued expenses	713,678	500,117
Income taxes payable		1,111,143
Excise taxes payable	49,880
Warrant liability	596,080	680,940
Total current liabilities	2,162,638	2,767,200
Deferred underwriting fee payable	14,490,000	14,490,000
Total liabilities	16,652,638	17,257,200
Commitments
Shares subject to possible redemption, 611,157 and 1,097,741, at September 30, 2023 and December 31, 2022, respectively, at redemption value	6,306,990	11,152,340
Stockholders’ Equity (Deficit):
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding
Additional paid in capital
Accumulated deficit	(16,567,981)	(15,937,070)
Total stockholders’ equity (deficit)	(16,566,846)	(15,935,935)
Total liabilities and stockholders’ equity (deficit)	6,392,782	12,473,605
Class A Common Stock
Stockholders’ Equity (Deficit):
Common stock	1,135	100
Class B Common Stock
Stockholders’ Equity (Deficit):
Common stock		1,035
Related Party
Current liabilities:
Promissory Note payable - related party, at fair value	$ 803,000	$ 475,000

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Shares subject to possible redemption value	611,157	1,097,741
Preferred shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, shares outstanding
Class A Common Stock
Shares subject to possible redemption value	11,964,156
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	11,352,999	1,003,000
Common stock, shares outstanding	11,352,999	1,003,000
Class B Common Stock
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	1	10,350,000
Common stock, shares outstanding	1	10,350,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
Condensed Statements of Operations (Unaudited) - USD ($)	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Formation costs and other operating expenses	$ 235,945	$ 215,357	$ 657,639	$ 827,471
Loss from operations	(235,945)	(215,357)	(657,639)	(827,471)
Other income:
Interest income	95,140	1,827,208	260,605	2,389,901
Change in fair value of warrant liability	426,360	932,205	84,860	6,196,840
(Loss) income before income taxes	285,555	2,544,056	(312,174)	7,759,270
Income tax expense	4,484		54,727
Net (loss) income	$ 281,071	$ 2,544,056	$ (366,901)	$ 7,759,270
Class A Redeemable Common Stock
Other income:
Weighted average shares outstanding common stock (in Shares)	806,848	41,400,000	999,711	41,400,000
Basic net income (loss) per share (in Dollars per share)	$ 0.2	$ 0.06	$ 0.21	$ 0.16
Class A and Class B Non- Redeemable Common Stock
Other income:
Weighted average shares outstanding common stock (in Shares)	11,353,000	11,353,000	11,353,000	11,353,000
Basic net income (loss) per share (in Dollars per share)	$ 0.01	$ 0.01	$ (0.05)	$ 0.1

Condensed Statements of Opera_2

Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Class A Redeemable Common Stock
Diluted net income (loss) per share	$ 0.20	$ 0.06	$ 0.21	$ 0.16
Class A and Class B Non- Redeemable Common Stock
Diluted net income (loss) per share	$ 0.01	$ 0.01	$ (0.05)	$ 0.10

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)	Class A Common Stock	Class B Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 100	$ 1,035		$ (21,155,409)	$ (21,154,274)
Balance (in Shares) at Dec. 31, 2021	1,003,000	10,350,000
Common Stock subject to redemption				(407,872)	(407,872)
Net income (loss)				5,215,214	5,215,214
Balance at Jun. 30, 2022	$ 100	$ 1,035		(16,348,067)	(16,346,932)
Balance (in Shares) at Jun. 30, 2022	1,003,000	10,350,000
Balance at Dec. 31, 2021	$ 100	$ 1,035		(21,155,409)	(21,154,274)
Balance (in Shares) at Dec. 31, 2021	1,003,000	10,350,000
Net income (loss)					7,759,270
Balance at Sep. 30, 2022	$ 100	$ 1,035		(15,631,218)	(15,630,083)
Balance (in Shares) at Sep. 30, 2022	1,003,000	10,350,000
Balance at Jun. 30, 2022	$ 100	$ 1,035		(16,348,067)	(16,346,932)
Balance (in Shares) at Jun. 30, 2022	1,003,000	10,350,000
Common Stock subject to redemption				(1,827,207)	(1,827,207)
Net income (loss)				2,544,056	2,544,056
Balance at Sep. 30, 2022	$ 100	$ 1,035		(15,631,218)	(15,630,083)
Balance (in Shares) at Sep. 30, 2022	1,003,000	10,350,000
Balance at Dec. 31, 2022	$ 100	$ 1,035		(15,937,070)	(15,935,935)
Balance (in Shares) at Dec. 31, 2022	1,003,000	10,350,000
Common Stock subject to redemption			(75,687)	(115,223)	(190,910)
Common Stock redeemed			75,687		75,687
Net income (loss)				(647,972)	(647,972)
Balance at Jun. 30, 2023	$ 100	$ 1,035		(16,700,265)	(16,699,130)
Balance (in Shares) at Jun. 30, 2023	1,003,000	10,350,000
Balance at Dec. 31, 2022	$ 100	$ 1,035		(15,937,070)	(15,935,935)
Balance (in Shares) at Dec. 31, 2022	1,003,000	10,350,000
Net income (loss)					(366,901)
Balance at Sep. 30, 2023	$ 1,135			(16,567,981)	(16,566,846)
Balance (in Shares) at Sep. 30, 2023	11,352,999	1
Balance at Jun. 30, 2023	$ 100	$ 1,035		(16,700,265)	(16,699,130)
Balance (in Shares) at Jun. 30, 2023	1,003,000	10,350,000
Common Stock subject to redemption	$ 49		4,987,927		4,987,976
Common Stock subject to redemption (in Shares)	486,584
Common Stock redeemed	$ (49)		(4,987,927)	(98,907)	(5,086,883)
Common Stock redeemed (in Shares)	(486,584)
Conversion of Class B common stock to Class A common stock	$ 1,035	$ (1,035)
Conversion of Class B common stock to Class A common stock (in Shares)	10,349,999	(10,349,999)
Excise tax imposed common stock redemption				(49,880)	(49,880)
Net income (loss)				281,071	281,071
Balance at Sep. 30, 2023	$ 1,135			$ (16,567,981)	$ (16,566,846)
Balance (in Shares) at Sep. 30, 2023	11,352,999	1

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
Condensed Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2023	Sep. 30, 2022
Cash flow from operating activities:
Net (loss) income	$ (366,901)	$ 7,759,270
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest earned in Trust Account	(260,605)	(2,235,080)
Change in fair value of warrant liability	(84,860)	(6,196,840)
Changes in operating assets and liabilities:
Prepaid expenses	(10,129)	168,382
Accounts payable and accrued expenses	213,561	(205,040)
Income taxes payable	(1,126,416)
Net cash used in operating activities	(1,635,350)	(709,308)
Cash flows from investing activities:
Redemption of cash in Trust Account	7,290,704
Recoveries of excess Trust Account Redemptions	(1,073,606)
Net cash provided by investing activities	6,217,098
Cash flows from financing activities:
Repayment of promissory note - related party	(50,000)	(5,000)
Proceeds of promissory note - related party	378,000	445,000
Redemption of Class A common stock	(5,059,480)
Net cash (used in) provided by financing activities	(4,731,480)	440,000
Net change in cash	(149,732)	(269,308)
Cash at the beginning of the period	180,109	336,290
Cash at the end of the period	30,377	66,982
Cash paid during the period for:
Income taxes	1,181,143
Supplemental disclosures of noncash investing and financing activities:
Excise tax liabilities accrued for common stock with redemptions	$ 49,880

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
Description of Organization and Business Operations	Sep. 30, 2023
Description of Organization and Business Operations [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Thunder Bridge Capital Partners III, Inc. (the “Company,” our “Company,” “we,” or “us” ) is a blank check company incorporated in Delaware on June 12, 2020. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2023, the Company had not yet commenced any operations. All activity for the period of June 12, 2020 (inception) through September 30, 2023 related to the Company’s formation, the initial public offering that was consummated by the Company on February 10, 2021 (the “Initial Public Offering”) and subsequent to the completion of the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Registration Statement on Form S-1 for the Initial Public Offering, initially filed with the Securities and Exchange Commission (the “SEC”) on January 15, 2021, as amended (File No. 333- 252109) was declared effective on February 4, 2021 (the “Registration Statement”). On February 10, 2021, the Company consummated the Initial Public Offering of 41,400,000 units and (ii) redeemable warrants included in the Units offered, the “Public Warrants” , generating gross proceeds of $414,000,000 (see Note 3). Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 1,003,000 units (the “Private Placement Units”) at a price of $10.00 per unit in a private placement to TBCP III, LLC (the “Sponsor”), generating gross proceeds of $10,030,000 (the “Private Placement”) (see Note 4). The Private Placement Units consist of one share of Class A common stock (the “Private Placement Shares”), and one-fifth of one redeemable warrant (the “Private Placement Warrants” ). Each whole Private Placement Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share. Following the closing of the Initial Public Offering on February 10, 2021, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Units in the Private Placement was placed in an U.S.-based trust account (“Trust Account”) which were initially invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, on February 28, 2023, Continental at Morgan Stanley, with Continental continuing to act as trustee, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below. The Company’s executive officers and directors (“Management”) has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of the Nasdaq Stock Market LLC (“Nasdaq”) provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the amended and restated certificate of incorporation of the Company currently in effect, as amended (the “Amended and Restated Certificate of Incorporation”) provides that, a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent. The Public Stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters of the Initial Public Offering (see Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the warrants. These shares of Class A common stock will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Sponsor has agreed (a) to vote its Founder Shares (as defined in Note 5), the Private Placement Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) and Private Placement Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders’ rights of pre-Business Combination activity and (d) that the Founder Shares and Private Placement Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its stockholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. The Company completed its Initial Public Offering, at which time, capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses was released to the Company for general working capital purposes. Additionally, the Sponsor executed the Promissory Note (as defined in Note 5) to loan the Company up to $1,500,000. Through September 30, 2023, the Company has borrowed $803,000 under the Promissory Note and $647,000 remains available to finance transaction costs in connection with the initial Business Combination. Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the accompanying unaudited condensed financial statements, which do not include any adjustments that might result from the outcome of this uncertainty. Extension of the Combination Period The Company initially had until February 10, 2023, 24 months from the closing of the Initial Public Offering, On December 30, 2022, an initial redemption payment was made by Continental, as trustee of the Trust Account, to the Redeeming Stockholders at a rate of $10.10 per share and, on January 11, 2023, Continental made an additional redemption payment (the “Additional Payment”) to the Redeeming Stockholders at a rate of $0.02841302 per share, for a total redemption payment per share of $10.12841302. It was later determined that the Company did not withdraw all of the interest from the Trust Account that it was allowed to withdraw to cover income and franchise taxes and, therefore, the Additional Payment should have been $0.00157381 per share, for a total redemption payment of $10.10157381 per share in the First Redemption. This meant that the Redeeming Stockholders were overpaid in the amount of $0.02683921 per share (the “Overpayment Amount”). The Redeeming Stockholders were notified of this situation and were instructed to return the Overpayment Amount to Continental. To date, the Company has recovered substantially all of the Overpayment Amount. On August 4, 2023, the Company held a special meeting of its stockholders in lieu of an annual meeting of stockholders (the “2023 Special Meeting”) at which its stockholders approved, among other things, an amendment to the Amended and Restated Certificate of Incorporation to (i) extend the Combination Period from August 10, 2023 to February 10, 2024 (or such earlier date as determined by the Board) (the “Second Extension Amendment Proposal”) and (ii) provide for the right of a holder of shares of Class B common stock to convert such shares into shares of Class A common stock on a one-for-one basis prior to the closing of a Business Combination (the “Founder Share Amendment Proposal” and together with the Second Extension Amendment Proposal, the “Charter Amendment Proposals”). In connection with the vote to approve the Charter Amendment Proposals, t he holders of 486,584 shares of Class A common stock properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.25 per share, for an aggregate redemption amount of approximately $5.0 million (the “Second Redemption”). 11,964,156 If the Company is unable to complete a Business Combination by the end of the Combination Period, pursuant to the Amended and Restated Certificate of Incorporation, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the Public Shares in consideration of a per-share price, payable in cash, equal to the quotient obtained by dividing (A) the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes (less up to $100,000 of such net interest to pay dissolution expenses), by (B) the total number of then outstanding Public Shares, which redemption will completely extinguish rights of the Public Stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board of Directors in accordance with applicable law, dissolve and liquidate, subject in each case to the Company’s obligations under the General Corporation Law of the State of Delaware (the “DGCL”) to provide for claims of creditors and other requirements of applicable law. The underwriters of the Initial Public Offering have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023 (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the Excise Tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the Excise Tax. Whether and to what extent the Company would be subject to the Excise Tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the Excise Tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the Excise Tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. In connection with the stockholders’ vote at the 2023 Special Meeting, Public Stockholders exercised their right to redeem 486,584 approximately $5.0 million in the Second Redemption Nasdaq Deficiency Notice On June 15, 2023, the Company received a deficiency letter (the “MVLS Notice”) from the Listing Qualifications Department (the “Staff”) of Nasdaq notifying the Company that, for the preceding 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the $35 million minimum requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). The notification received had no immediate effect on the Company’s Nasdaq listing. In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or until December 21, 2023 (the “Compliance Date”), to regain compliance with the MVLS Requirement. If, at any time before the Compliance Date, the Company’s MVLS closes at $35 million or more for a minimum of 10 consecutive business days, the Staff will provide the Company with written confirmation of compliance with the MVLS Requirement. On November 8, 2023, the Company received a follow-up letter to the MVLS Notice from the Staff of Nasdaq notifying the Company that it had regained compliance with the MVLS Requirement and that the matter was closed.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Liquidity and Going Concern Consideration As of September 30, 2023, the Company had a working capital deficit of approximately $2,077,000, which represents the aggregate amount of Excise Tax and other accrued liabilities of $2,162,638 in excess of the Company’s cash of $30,000 and prepaid expenses. The Company’s liquidity needs to date have been satisfied through (i) a contribution of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, (ii) an advance from an affiliate of the Sponsor of the payment of certain formation and operating costs on behalf of the Company and (iii) the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, as of September 30, 2023 and December 31, 2022, there was $803,000 and $475,000, respectively, outstanding under the Promissory Note (see Note 5). In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern” (“ASC 205-40”), the Company has evaluated its liquidity and financial condition and determined that it is probable the Company will not be able to meet its obligations over the period of one year from the issuance date of the accompanying unaudited condensed financial statements. In addition, while the Company plans to seek additional funding or to consummate an initial Business Combination, there is no guarantee the Company will be able to borrow such funds from its Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors in order to meet its obligations through the earlier of the consummation of an initial Business Combination or one year from this filing. The Company has determined that the uncertainty surrounding its liquidity condition raises substantial doubt about its ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,377 and $180,109 in cash and did not have any cash equivalents as of September 30, 2023 and December 31, 2022, respectively. Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. Offering Costs The Company complies with the requirements of FASB ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs are charged against the carrying value of Class A common stock or the statement of operations based on the relative value of the Class A common stock and the Public Warrants to the proceeds received from the Units sold upon the completion of the Initial Public Offering. Accordingly, offering costs in the aggregate of $23,191,740 were recognized, $463,835 of which was allocated to the warrants and immediately expensed included in formation costs and other operating expenses, and $22,727,905 was allocated to Class A common stock, reducing the carrying amount of such shares. Cash Held in Trust Account On February 28, 2023, the Company instructed Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account at Morgan Stanley, with Continental continuing to act as trustee, until the earlier of the consummation of the Business Combination or liquidation. As a result, at September 30, 2023, the assets held in the Trust Account were invested in an interest-bearing demand deposit account at a bank. Shares Subject to Possible Redemption All of the Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature that allows for the redemption of such shares (i) in connection with the Company’s liquidation, (ii) if there is a shareholder vote or tender offer in connection with the Business Combination and (iii) in connection with certain amendments to the Amended and Restated Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, such shares are classified as stockholders’ equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, as of September 30, 2023 and December 31, 2022, 611,157 and 1,097,741 shares of Class A common stock, respectively, representing the Public Shares, subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ equity (deficit) section of the accompanying condensed balance sheets. . The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of common stock are affected by charges against shares of common stock and accumulated deficit. Net Income (Loss) Per Share of Common Stock The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The Company has two classes of shares, the (i) Class A common stock subject to possible redemption and non-redeemable Class A common stock and (ii) Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the period. The calculation of diluted net income (loss) per share does not consider the effect of the Public Warrants issued in connection with the Initial Public Offering and the sale of the Private Placement Warrants in the Private Placement, because the exercise of the warrants is contingent upon the occurrence of future events, and any shares that can be issued in the settlement of the Promissory Note payable. A reconciliation of net income (loss) per share of common stock is as follows: For the Three Months For the Nine Months 2023 2022 2023 2022 Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption $ 281,071 $ 2,544,056 $ (366,901 ) $ 7,759,270 Accretion of redeemable common stock to redemption amount (98,907 ) (1,827,207 ) (214,130 ) (2,235,079 ) Excise taxes on stock redemption (49,880 ) - (49,880 ) - Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption $ 132,284 $ 716,849 $ (630,911 ) $ 5,524,191 For the Three Months For the Three Months For the Six Months For the Six Months Redeemable Non- Redeemable Non- Redeemable Non- Redeemable Non- Basic and diluted net income (loss) per share Numerator: Allocation of net income (loss) including accretion of temporary equity to redemption value $ 8,778 $ 123,506 $ 562,576 $ 154,273 $ (51,060 ) $ (579,851 ) $ 4,335,327 $ 1,188,864 Excise taxes on stock redemption 49,880 - - - 49,880 - - - Accretion applicable to Class A redeemable shares 98,907 - 1,827,207 - 214,130 - 2,235,079 - Income (loss) by class $ 157,565 $ 123,506 $ 2,389,783 $ 154,273 $ 212,950 $ (579,851 ) $ 6,570,406 $ 1,188,864 Denominator: Basic and diluted weighted average common shares outstanding 806,848 11,353,000 41,400,000 11,353,000 999,711 11,353,000 41,400,000 11,353,000 Basic and diluted net income (loss) per share $ 0.20 $ 0.01 $ 0.06 $ 0.01 $ 0.21 $ (0.05 ) $ 0.16 $ 0.10 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and Management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature. Derivative Financial Instruments The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the accompanying unaudited condensed statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the accompanying condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Warrants The Company accounts for the Public Warrants and Private Placement Warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants (i) are freestanding financial instruments pursuant to ASC 480, (ii) meet the definition of a liability pursuant to ASC 480, and (iii) meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the stockholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the accompanying unaudited condensed statements of operations. Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements. Subsequent Events Management of the Company evaluates events that have occurred after the balance sheet date of September 30, 2023, through the date the financial statements were issued. Based upon the review, Management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements, On November 8, 2023, the Company received a follow-up letter from the Staff of Nasdaq notifying the Company that it had regained compliance with the MVLS Requirement and that the matter was closed (see Note 1).

Initial Public Offering

Initial Public Offering	9 Months Ended
Initial Public Offering	Sep. 30, 2023
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING On February 10, 2021, 41,400,000 Units at a purchase price of $10.00 per Unit, Each Unit consists of one Public Share and one-fifth of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 7).

Private Placement

Private Placement	9 Months Ended
Private Placement	Sep. 30, 2023
Private Placement [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the Initial Public Offering, the Sponsor purchased an aggregate of 1,003,000 Private Placement Units at a price of $10.00 per unit for an aggregate purchase price of $10,030,000 in the Private Placement. Each Private Placement Unit is identical to the Units offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Shares or Private Placement Warrants, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period.

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On August 26, 2020, the Company issued an aggregate of 8,625,000 shares of Class B common stock (the “Founder Shares”) to the Sponsor for an aggregate purchase price of $25,000. In February 2021, the Company effected a stock dividend of 0.2 shares for each Founder Share outstanding, resulting in the Sponsor holding an aggregate number of 10,350,000 Founder Shares. The Founder Shares included an aggregate of up to 1,350,000 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would collectively own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). February 10, 2021, The Sponsor has agreed not to transfer, assign, or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s stockholders having the right to exchange their shares of common stock for cash, securities, or other property. Notwithstanding the foregoing, if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up. On August 7, 2023, the Company issued an aggregate of 10,349,999 shares of Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares (the “Founder Share ”). The 10,349,999 shares of Class A common stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B common stock before the Founder Share Conversion, including, as described above. As a result of the Founder Share Conversion and the Second Redemption, the Sponsor holds approximately 94.9% of the issued and outstanding shares of Class A common stock. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into units at a price of $10.00 per unit. The units will be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On March 25, 2022, the Company executed a promissory note, representing a Working Capital Loan from the Sponsor, for the Sponsor to loan funds to the Company up to $1,500,000 (the “Promissory Note”). At September 30, 2023 and December 31, 2022 there was $803,000 and $475,000 outstanding under the Promissory Note, respectively. The fair value of the Promissory Note as of September 30, 2023 and December 31, 2022 was $803,000 and $475,000, respectively, with changes in fair value recorded to the accompanying unaudited condensed statements of operations. For the three and nine months ended September 30, 2023, there were no changes in fair value recorded to the accompanying unaudited condensed statements of operations. Administrative Support Agreement The Company entered into an agreement, whereby, commencing on February 10, 2021, through the earlier of the consummation of a Business Combination or the Company’s liquidation, the Company pays an affiliate of the Sponsor a total of $10,000 per month for office space, utilities, and secretarial and administrative support. The Company had incurred $30,000 and $90,000 for the three and nine months ended September 30, 2023 and 2022, respectively. As of September 30, 2023, the Company has an unpaid balance of $70,000 due to such affiliate of the Sponsor under the Administrative Support Agreement. Advisory Agreement The Company entered into an agreement, whereby, commencing on February 10, 2021, through the earlier of the consummation of a Business Combination or the Company’s liquidation, the Company pays an affiliate of its Chief Executive Officer a monthly fee of $20,000 for advisory services related to its search for and consummation of its Business Combination. The Company had incurred $60,000 and $180,000 for the three and nine months ended September 30, 2023 and 2022, respectively. Initial Public Offering In February 2021, our Chief Executive Officer purchased 100,000 Units at a price of $10.00 per Unit for an aggregate purchase price of $1,000,000 as part of our Initial Public Offering.

Commitments

Commitments	9 Months Ended
Commitments	Sep. 30, 2023
Commitments [Abstract]
COMMITMENTS	NOTE 6. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on February 10, 2021, the holders of the Founder Shares, Private Placement Units (and their underlying securities) and the units that may be issued upon conversion of the Working Capital Loans (and their underlying securities) are entitled to registration rights. The holders of a majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters of the Initial Public Offering a 45-day option to purchase up to 5,400,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions, which was exercised on February 10, 2021. The underwriters were paid a cash underwriting discount of two percent (2.00%) of the gross proceeds of the Initial Public Offering, or $8,280,000. In addition, the underwriters are entitled to a deferred underwriting discount of three and half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $14,490,000. The deferred fee was placed in the Trust Account and will be paid in cash upon the closing of a Business Combination, subject to the terms of the underwriting agreement.

Warrants

Warrants	9 Months Ended
Warrants	Sep. 30, 2023
Warrants [Abstract]
WARRANTS	NOTE 7. WARRANTS Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the Business Combination, it will use its best efforts to file with the SEC, and within 60 business days following the Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60 th Once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders. In addition, once the Public Warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.10 per Public Warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder, provided that holders will be able to exercise their Public Warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to a formula set out in the warrant agreement; ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within a 30-trading day period commencing no earlier than the date the warrants become exercisable and ending on the third business day before the date on which the Company sends the notice of redemption to the warrant holders (the “30-day Reference Period”); and ● unless the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) for any 20 trading days within the 30-day Reference Period, the Private Placement Warrants are also concurrently redeemed at the same price and terms as the outstanding Public Warrants (provided that the redemption may be on a cashless basis). If and when the Public Warrants become redeemable by the Company, it may exercise its redemption rights even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws; provided, that the Company will use its best efforts to register or qualify such shares of common stock under the blue sky laws of the state of residence in those states in which the Public Warrants were offered by the Company in the Initial Public Offering. The exercise price and number of shares of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger, or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants, except in the event of certain tender offers, as defined in the warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of the Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Board of Directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the greater of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants will and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees (other than in the case the Public Warrants are redeemed for $0.10 as described above). If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The warrant agreement, dated February 4, 2021, by and between the Company and Continental, contains an Alternative Issuance provision that if less than 70% of the consideration receivable by the holders of the Class A common stock in the Business Combination is payable in the form of common equity in the successor entity, and if the holders of the warrants properly exercise the warrants within thirty days following the public disclosure of the consummation of Business Combination by the Company, the warrant price shall be reduced by an amount equal to the difference (but in no event less than zero) of (i) the warrant price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration paid to holders of the common stock consists exclusively of cash, the amount of such cash per common stock, and (ii) in all other cases, the volume weighted average price of the common stock as reported during the ten-trading day period ending on the trading day prior to the effective date of the Business Combination. At September 30, 2023, there were 8,280,000 whole Public Warrants and 200,600 Private Placement Warrants outstanding with a fair value of $579,600 and $16,480, respectively. At December 31, 2022, there were 8,280,000 whole Public Warrants and 200,600 Private Placement Warrants outstanding with a fair value of $662,400 and $18,540, respectively. The Company accounts for the 8,280,000 Public Warrants and the 200,600 Private Placement Warrants issued and outstanding in accordance with the guidance contained in ASC 815–40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a derivative liability. The Company believes that the adjustments to the exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815–40, and thus the warrants are not eligible for an exception from derivative accounting. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Initial Public Offering. Accordingly, the Company classifies each warrant as a liability at its fair value and the warrants have been allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation. This liability is subject to re-measurement at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the accompanying unaudited condensed statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit)	9 Months Ended
Stockholders’ Equity (Deficit)	Sep. 30, 2023
Stockholders’ Equity [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	NOTE 8. STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock The Company is authorized to issue 1,000,000 shares of $0.0001 par value preferred stock. At September 30, 2023 and December 31, 2022 , there were no Class A Common Stock The Company is authorized to issue up to 200,000,000 shares of Class A, $0.0001 par value common stock. Holders of the Class A common stock are entitled to one vote for each share. At December 31, 2022, there were 1,003,000 shares of Class A common stock issued and outstanding (excluding 1,097,741 Class A shares subject to possible redemption). In connection with the vote to approve the Extension Amendment Proposal at the 2022 Special Meeting, Redeeming Stockholders properly exercised their right to redeem 40,302,259 Public Shares for cash in the First Redemption. In connection with the vote to approve the Charter Amendment Proposals at the 2023 Special Meeting, the holders of 486,584 shares of Class A common stock properly exercised their right to redeem their shares for cash at a redemption price of approximately $10.25 per share, for an aggregate redemption amount of approximately $5.0 million in the Second Redemption. As a result of the Founder Share Conversion and the Second Redemption, as of September 30. 2023, there were 11,352,999 shares of Class A common stock issued and outstanding (excluding 611,157 Class A shares subject to possible redemption). Class B Common Stock The Company is authorized to issue up to 20,000,000 shares of Class B, $0.0001 par value common stock. Holders of the Class B common stock are entitled to one vote for each share. On February 4, 2021, the Company effectuated a 1.2 for 1 dividend of the Class B common stock resulting in an aggregate of 10,350,000 shares of Class B common stock issued and outstanding. At , there were 10,350,000 shares of Class B common stock issued and outstanding. On August 7, 2023, the Company issued an aggregate of 10,349,999 shares of Class A common stock to the Sponsor upon the conversion of an equal number of shares of Class B common stock held by the Sponsor as Founder Shares in the Founder Share . The 10,349,999 shares of Class A common stock issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B common stock before the Founder Share Conversion, including, as described above. Following the Founder Share Conversion and the Second Redemption, at September 30, 2023 Holders of Class A common stock and Class B common stock vote together as a single class on all other matters submitted to a vote of stockholders, except as required by law; provided that only holders of Class B common stock have the right to vote for the election of directors prior to the Business Combination. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations, and the like. In the case that additional shares of Class A common stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any Private Placement-equivalent units and its underlying securities issued to the Sponsor or its affiliates upon conversion of loans made to the Company). As a result of the 2023 Special Meeting and the stockholders’ approval of the Founder Share Amendment Proposal, holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. The Company may issue additional common stock or preferred stock to complete its Business Combination or under an employee incentive plan after completion of its Business Combination

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2023
Fair Value Measurements [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 9. FAIR VALUE MEASUREMENTS “Fair value” is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● “Level 1”, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● “Level 2”, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● “Level 3”, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, December 31, Assets: Cash and marketable securities held in Trust Account 1 $ 6,306,990 $ 12,263,483 Liabilities: Public Warrants 1 $ 579,600 $ 662,400 Private Placement Warrants 2 16,480 18,540 Promissory Note payable – related party, at fair value 3 803,000 475,000 The warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the accompanying ondensed statements of operations. Initial Measurement The Company established the initial fair value for the warrants on February 10, 2021, the date of the Initial Public Offering, using a Monte Carlo simulation and Black-Scholes Merton formula for the Private Placement Warrants and the Public Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Public Share and one-fifth of one Public Warrant), and (ii) the sale of Private Placement Units, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to shares of Class A common stock subject to possible redemption based on their relative fair values at the initial measurement date. The Private Placement Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows: February 10, Input 2021 Risk-free interest rate 74.00 % Expected term to consummate the Business Combination (years) 6.5 Expected Volatility 15 % Exercise Price $ 11.50 Stock price $ 9.80 The Company’s use of a Monte Carlo simulation and Black-Scholes Merton formula required the use of subjective assumptions: ● The risk-free interest rate assumption was based on the 6.5 year yield the yield on the Treasury notes as of the Valuation Date that matched the time period to consummate the Business Combination as of each Valuation Date. ● The expected term was simulated out daily over the expected remaining life of the Public Warrants. The specific remaining life was based on Management’s estimated time to consummate the Business Combination as well as the five-year contractual period that begins once the transaction closes. ● The expected volatility assumption was based on the implied volatility from a set of comparable publicly-traded warrants as determined based on the size and proximity of other similar business combinations. An increase in the expected volatility, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. ● The fair value of the Units, which each consist of one Public Share and one-fifth of one Public Warrant, represents the closing price on the measurement date as observed from the ticker “TBCP”. Based on the applied volatility assumption and the expected term to a Business Combination noted above, the Company determined that the risk neutral probability of exceeding the $18.00 redemption value by the start of the exercise period for the warrants resulted in a nominal difference in value between the Public Warrants and Private Placement Warrants across the valuation dates utilized in the Monte Carlo simulation model. Therefore, the resulting valuations for the two classes of warrants were determined to be equal. On February 10, 2021, the Private Placement Warrants and Public Warrants were determined to be $1.57 per warrant for aggregate values of $12.6 million and $31.6 million, respectively. Subsequent Measurement The warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of September 30, 2023 and December 31, 2022 is classified as Level 1 due to the use of an observable market quote in an active market under the ticker “TBCPW”. As the transfer of Private Placement Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is classified as Level 2, due to the use of observable inputs. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at the subsequent measurement date: Input September 30, Risk-free interest rate 4.60 % Expected term (years) 5 Expected term to consummate the Business Combination (years) 0.25 Expected Volatility 25.7 % Exercise Price $ 11.50 Stock price $ 10.24 As of September 30, 2023, the aggregate values of the Private Placement Warrants and Public Warrants were approximately $1.02 million. The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Fair value as of January 1, 2023 $ 18,540 $ 662,400 $ 680,940 Change in valuation inputs or other assumptions (1) (2,060) (82,800 ) (84,860 ) Fair value as of September 30, 2023 $ 16,480 $ 579,600 $ 596,080 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the accompanying unaudited condensed statements of operations. The following table present the changes in fair value of the Level 3 Promissory Note- related party: Fair value as of January 1, 2023 $ 475,000 Repayment of Promissory Note - Related Party (50,000 ) Advances on Promissory Note – Related Party 378,000 Change in fair value - Fair value as of September 30, 2023 $ 803,000 There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and nine months ended September 30, 2023 for the Promissory Note.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2023
Income Taxes [Abstract]
INCOME TAXES	NOTE 10. INCOME TAXES As of September 30, 2023 and December 31, 2022, the Company’s net deferred tax assets are as follows: 2023 2022 Deferred tax asset: Organizational costs/Startup expenses $ 568,395 $ 386,136 Total deferred tax asset 568,395 386,136 Valuation allowance (568,395 ) (386,136 ) Deferred tax asset, net of allowance $ - $ - The Company will file taxes in the U.S. Federal jurisdiction. We have $0 and $0 in net operating loss carryovers at September 30, 2023 and 2022, respectively. We are subject to taxation in the United States. As of December 31, 2022, we have no tax years under examination by the Internal Revenue Service. The U.S. federal tax returns for tax years 2022 and 2021 remain open to examination by the tax authorities. We have established a full valuation allowance for our deferred tax assets for the nine months ended September 30, 2023, and for the year ended December 31, 2022, as it is more likely than not that these assets will not be realized in the foreseeable future. Our valuation allowance increased by $128,364 from December 31, 2022 to September 30, 2023.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
Accounting Policies, by Policy (Policies)	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Liquidity and Going Concern Consideration	Liquidity and Going Concern Consideration As of September 30, 2023, the Company had a working capital deficit of approximately $2,077,000, which represents the aggregate amount of Excise Tax and other accrued liabilities of $2,162,638 in excess of the Company’s cash of $30,000 and prepaid expenses. The Company’s liquidity needs to date have been satisfied through (i) a contribution of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, (ii) an advance from an affiliate of the Sponsor of the payment of certain formation and operating costs on behalf of the Company and (iii) the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, as of September 30, 2023 and December 31, 2022, there was $803,000 and $475,000, respectively, outstanding under the Promissory Note (see Note 5). In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern” (“ASC 205-40”), the Company has evaluated its liquidity and financial condition and determined that it is probable the Company will not be able to meet its obligations over the period of one year from the issuance date of the accompanying unaudited condensed financial statements. In addition, while the Company plans to seek additional funding or to consummate an initial Business Combination, there is no guarantee the Company will be able to borrow such funds from its Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors in order to meet its obligations through the earlier of the consummation of an initial Business Combination or one year from this filing. The Company has determined that the uncertainty surrounding its liquidity condition raises substantial doubt about its ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company, which is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,377 and $180,109 in cash and did not have any cash equivalents as of September 30, 2023 and December 31, 2022, respectively.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction.
Offering Costs	Offering Costs The Company complies with the requirements of FASB ASC Topic 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs are charged against the carrying value of Class A common stock or the statement of operations based on the relative value of the Class A common stock and the Public Warrants to the proceeds received from the Units sold upon the completion of the Initial Public Offering. Accordingly, offering costs in the aggregate of $23,191,740 were recognized, $463,835 of which was allocated to the warrants and immediately expensed included in formation costs and other operating expenses, and $22,727,905 was allocated to Class A common stock, reducing the carrying amount of such shares.
Cash Held in Trust Account	Cash Held in Trust Account On February 28, 2023, the Company instructed Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand deposit account at Morgan Stanley, with Continental continuing to act as trustee, until the earlier of the consummation of the Business Combination or liquidation. As a result, at September 30, 2023, the assets held in the Trust Account were invested in an interest-bearing demand deposit account at a bank.
Shares Subject to Possible Redemption	Shares Subject to Possible Redemption All of the Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature that allows for the redemption of such shares (i) in connection with the Company’s liquidation, (ii) if there is a shareholder vote or tender offer in connection with the Business Combination and (iii) in connection with certain amendments to the Amended and Restated Certificate of Incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, such shares are classified as stockholders’ equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, as of September 30, 2023 and December 31, 2022, 611,157 and 1,097,741 shares of Class A common stock, respectively, representing the Public Shares, subject to possible redemption at the redemption amount were presented at redemption value as temporary equity, outside of the stockholders’ equity (deficit) section of the accompanying condensed balance sheets. . The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares of common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares of common stock are affected by charges against shares of common stock and accumulated deficit.
Net Income (Loss) Per Share of Common Stock	Net Income (Loss) Per Share of Common Stock The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The Company has two classes of shares, the (i) Class A common stock subject to possible redemption and non-redeemable Class A common stock and (ii) Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding during the period. The calculation of diluted net income (loss) per share does not consider the effect of the Public Warrants issued in connection with the Initial Public Offering and the sale of the Private Placement Warrants in the Private Placement, because the exercise of the warrants is contingent upon the occurrence of future events, and any shares that can be issued in the settlement of the Promissory Note payable. A reconciliation of net income (loss) per share of common stock is as follows: For the Three Months For the Nine Months 2023 2022 2023 2022 Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption $ 281,071 $ 2,544,056 $ (366,901 ) $ 7,759,270 Accretion of redeemable common stock to redemption amount (98,907 ) (1,827,207 ) (214,130 ) (2,235,079 ) Excise taxes on stock redemption (49,880 ) - (49,880 ) - Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption $ 132,284 $ 716,849 $ (630,911 ) $ 5,524,191 For the Three Months For the Three Months For the Six Months For the Six Months Redeemable Non- Redeemable Non- Redeemable Non- Redeemable Non- Basic and diluted net income (loss) per share Numerator: Allocation of net income (loss) including accretion of temporary equity to redemption value $ 8,778 $ 123,506 $ 562,576 $ 154,273 $ (51,060 ) $ (579,851 ) $ 4,335,327 $ 1,188,864 Excise taxes on stock redemption 49,880 - - - 49,880 - - - Accretion applicable to Class A redeemable shares 98,907 - 1,827,207 - 214,130 - 2,235,079 - Income (loss) by class $ 157,565 $ 123,506 $ 2,389,783 $ 154,273 $ 212,950 $ (579,851 ) $ 6,570,406 $ 1,188,864 Denominator: Basic and diluted weighted average common shares outstanding 806,848 11,353,000 41,400,000 11,353,000 999,711 11,353,000 41,400,000 11,353,000 Basic and diluted net income (loss) per share $ 0.20 $ 0.01 $ 0.06 $ 0.01 $ 0.21 $ (0.05 ) $ 0.16 $ 0.10
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and Management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.
Derivative Financial Instruments	Derivative Financial Instruments The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the accompanying unaudited condensed statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the accompanying condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrants	Warrants The Company accounts for the Public Warrants and Private Placement Warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants (i) are freestanding financial instruments pursuant to ASC 480, (ii) meet the definition of a liability pursuant to ASC 480, and (iii) meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the stockholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the accompanying unaudited condensed statements of operations.
Recently Issued Accounting Standards	Recently Issued Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the financial statements.
Subsequent Events	Subsequent Events Management of the Company evaluates events that have occurred after the balance sheet date of September 30, 2023, through the date the financial statements were issued. Based upon the review, Management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements, On November 8, 2023, the Company received a follow-up letter from the Staff of Nasdaq notifying the Company that it had regained compliance with the MVLS Requirement and that the matter was closed (see Note 1).

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Sep. 30, 2023
Accounting Policies [Abstract]
Schedule of Reconciliation of Net (Loss) Income Per Share of Common Stock	A reconciliation of net income (loss) per share of common stock is as follows: For the Three Months For the Nine Months 2023 2022 2023 2022 Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption $ 281,071 $ 2,544,056 $ (366,901 ) $ 7,759,270 Accretion of redeemable common stock to redemption amount (98,907 ) (1,827,207 ) (214,130 ) (2,235,079 ) Excise taxes on stock redemption (49,880 ) - (49,880 ) - Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption $ 132,284 $ 716,849 $ (630,911 ) $ 5,524,191
Schedule of Basic and diluted Net Income (Loss) Per Share	A reconciliation of net income (loss) per share of common stock is as follows: For the Three Months For the Three Months For the Six Months For the Six Months Redeemable Non- Redeemable Non- Redeemable Non- Redeemable Non- Basic and diluted net income (loss) per share Numerator: Allocation of net income (loss) including accretion of temporary equity to redemption value $ 8,778 $ 123,506 $ 562,576 $ 154,273 $ (51,060 ) $ (579,851 ) $ 4,335,327 $ 1,188,864 Excise taxes on stock redemption 49,880 - - - 49,880 - - - Accretion applicable to Class A redeemable shares 98,907 - 1,827,207 - 214,130 - 2,235,079 - Income (loss) by class $ 157,565 $ 123,506 $ 2,389,783 $ 154,273 $ 212,950 $ (579,851 ) $ 6,570,406 $ 1,188,864 Denominator: Basic and diluted weighted average common shares outstanding 806,848 11,353,000 41,400,000 11,353,000 999,711 11,353,000 41,400,000 11,353,000 Basic and diluted net income (loss) per share $ 0.20 $ 0.01 $ 0.06 $ 0.01 $ 0.21 $ (0.05 ) $ 0.16 $ 0.10

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2023
Fair Value Measurements [Abstract]
Schedule of Changes in Fair Value of the Level 3 Promissory Note- Related Party	The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, December 31, Assets: Cash and marketable securities held in Trust Account 1 $ 6,306,990 $ 12,263,483 Liabilities: Public Warrants 1 $ 579,600 $ 662,400 Private Placement Warrants 2 16,480 18,540 Promissory Note payable – related party, at fair value 3 803,000 475,000
Schedule of the Monte Carlo Simulation Model for the Private Placement Warrants and Public Warrants	The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows: February 10, Input 2021 Risk-free interest rate 74.00 % Expected term to consummate the Business Combination (years) 6.5 Expected Volatility 15 % Exercise Price $ 11.50 Stock price $ 9.80 Input September 30, Risk-free interest rate 4.60 % Expected term (years) 5 Expected term to consummate the Business Combination (years) 0.25 Expected Volatility 25.7 % Exercise Price $ 11.50 Stock price $ 10.24
Schedule of Changes in the Fair Value of Warrant Liabilities	The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Fair value as of January 1, 2023 $ 18,540 $ 662,400 $ 680,940 Change in valuation inputs or other assumptions (1) (2,060) (82,800 ) (84,860 ) Fair value as of September 30, 2023 $ 16,480 $ 579,600 $ 596,080 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the accompanying unaudited condensed statements of operations.
Schedule of Changes in Fair Value of the Level 3 Promissory Note- Related Party	The following table present the changes in fair value of the Level 3 Promissory Note- related party: Fair value as of January 1, 2023 $ 475,000 Repayment of Promissory Note - Related Party (50,000 ) Advances on Promissory Note – Related Party 378,000 Change in fair value - Fair value as of September 30, 2023 $ 803,000

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
Income Taxes (Tables)	Sep. 30, 2023
Income Taxes [Abstract]
Schedule of Company’s Net Deferred Tax Assets	As of September 30, 2023 and December 31, 2022, the Company’s net deferred tax assets are as follows: 2023 2022 Deferred tax asset: Organizational costs/Startup expenses $ 568,395 $ 386,136 Total deferred tax asset 568,395 386,136 Valuation allowance (568,395 ) (386,136 ) Deferred tax asset, net of allowance $ - $ -

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)				9 Months Ended
	Aug. 16, 2022	Feb. 10, 2021	Feb. 10, 2021	Sep. 30, 2023	Aug. 10, 2023	Jun. 15, 2023	Jan. 11, 2023	Dec. 31, 2022
Description of Organization and Business Operations [Line Items]
Gross proceeds from initial public offering (in Dollars)				$ 14,490,000
Fair market value, percentage				80%
Net tangible assets (in Dollars)				$ 5,000,001
Redemption of percentage of common stock included in units sold in offering				15%
Redemption per share				$ 10
Minimum amount of trust account per share				10
Minimum due to reductions in value of trust assets per share				$ 10
Loan amount (in Dollars)				$ 1,500,000
Borrowed promissory note (in Dollars)				803,000
Finance transaction costs (in Dollars)				$ 647,000,000
Share price							$ 10.12841302
Additional payment price				$ 0.00157381
Redemption payment price				10.10157381
Overpaid price				$ 0.02683921
Exercised shares (in Shares)				486,584
Redemption price				$ 10.25
Redemption amount (in Dollars)				$ 5,000,000
Common stock outstanding (in Shares)				611,157				1,097,741
Redeem public shares percenatge				100%
Net interest (in Dollars)				$ 100,000
Initial Public Offering price per Unit				$ (10)
Excise tax repurchases percentage	1%
Excise tax general percentage	1%
Excise tax amount (in Dollars)				$ 5,000,000
Excise tax liability (in Dollars)				$ 49,880
Share redemption				1%
Minimum market value (in Dollars)						$ 35,000,000
Closing market value (in Dollars)				$ 35,000,000
Initial Public Offering [Member]
Description of Organization and Business Operations [Line Items]
Number of units issued in transaction (in Shares)		41,400,000	41,400,000	1,003,000
Gross proceeds from initial public offering (in Dollars)			$ 414,000,000	$ 8,280,000
Unit price		$ 10	$ 10
Net proceeds (in Dollars)		$ 414,000,000	$ 414,000,000
Private Placement [Member]
Description of Organization and Business Operations [Line Items]
Number of units issued in transaction (in Shares)				1,003,000
Gross proceeds from initial public offering (in Dollars)				$ 10,030,000
Unit price				$ 10
Trust Account [Member]
Description of Organization and Business Operations [Line Items]
Share price					$ 10.1		$ 0.02841302
Class A Common Stock [Member]
Description of Organization and Business Operations [Line Items]
Exercise price		$ 11.5	$ 11.5	$ 11.5
Common stock issued (in Shares)				11,352,999				1,003,000
Exercised shares (in Shares)				486,584
Common stock issued (in Shares)				11,964,156
Common stock outstanding (in Shares)				11,964,156
Class A Common Stock [Member] \| Redeeming Stockholders [Member]
Description of Organization and Business Operations [Line Items]
Common stock issued (in Shares)					40,302,259
Business Combination [Member]
Description of Organization and Business Operations [Line Items]
Outstanding voting percentage				50%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies (Details) [Line Items]
Working capital deficit	$ 2,077,000
Excise tax and other accrued liabilities	2,162,638
Prepaid expenses	30,000
Expenses	25,000
Outstanding balance	803,000	$ 475,000
Cash	30,377	$ 180,109
Warrants expenses	$ 463,835
Shares subject to possible redemption value (in Shares)	611,157	1,097,741
Federal depository insurance corporation coverage	$ 250,000
IPO [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Offering costs	23,191,740
Class A Common Stock [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Carrying amount	$ 22,727,905
Shares subject to possible redemption value (in Shares)	11,964,156

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of Reconciliation of Net (Loss) Income Per Share of Common Stock - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Schedule Of Reconciliation Of Net Loss Income Per Share Of Common Stock Abstract
Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption	$ 281,071	$ 2,544,056	$ (647,972)	$ 5,215,214	$ (366,901)	$ 7,759,270
Accretion of redeemable common stock to redemption amount	(98,907)	(1,827,207)			(214,130)	(2,235,079)
Excise taxes on stock redemption	(49,880)				(49,880)
Net income (loss) including accretion of temporary equity to redemption value and excise taxes on stock redemption	$ 132,284	$ 716,849			$ (630,911)	$ 5,524,191

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of Basic and diluted Net Income (Loss) Per Share - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Redeemable [Member]
Numerator:
Allocation of net income (loss) including accretion of temporary equity to redemption value	$ 8,778	$ 562,576	$ (51,060)	$ 4,335,327
Excise taxes on stock redemption	49,880		49,880
Accretion applicable to Class A redeemable shares	98,907	1,827,207	214,130	2,235,079
Income (loss) by class	$ 157,565	$ 2,389,783	$ 212,950	$ 6,570,406
Denominator:
Basic and diluted weighted average common shares outstanding (in Shares)	806,848	41,400,000	999,711	41,400,000
Basic and diluted net income (loss) per share (in Dollars per share)	$ 0.2	$ 0.06	$ 0.21	$ 0.16
Non redeemable [Member]
Numerator:
Allocation of net income (loss) including accretion of temporary equity to redemption value	$ 123,506	$ 154,273	$ (579,851)	$ 1,188,864
Excise taxes on stock redemption
Accretion applicable to Class A redeemable shares
Income (loss) by class	$ 123,506	$ 154,273	$ (579,851)	$ 1,188,864
Denominator:
Basic and diluted weighted average common shares outstanding (in Shares)	11,353,000	11,353,000	11,353,000	11,353,000
Basic and diluted net income (loss) per share (in Dollars per share)	$ 0.01	$ 0.01	$ (0.05)	$ 0.1

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of Basic and diluted Net Income (Loss) Per Share (Parentheticals) - $ / shares	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Redeemable [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and diluted Net Income (Loss) Per Share (Parentheticals) [Line Items]
Diluted weighted average common shares outstanding	806,848	41,400,000	999,711	41,400,000
Diluted net income (loss) per share	$ 0.20	$ 0.06	$ 0.21	$ 0.16
Non redeemable [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Basic and diluted Net Income (Loss) Per Share (Parentheticals) [Line Items]
Diluted weighted average common shares outstanding	11,353,000	11,353,000	11,353,000	11,353,000
Diluted net income (loss) per share	$ 0.01	$ 0.01	$ (0.05)	$ 0.10

Initial Public Offering (Detail

Initial Public Offering (Details) - $ / shares			9 Months Ended
Initial Public Offering (Details) - $ / shares	Feb. 10, 2021	Feb. 10, 2021	Sep. 30, 2023
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Shares issued (in Shares)	41,400,000	41,400,000	1,003,000
Purchase price per share	$ 10	$ 10
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Shares issued (in Shares)	5,400,000
Purchase price per share	$ 10	10
Class A Common Stock [Member]
Initial Public Offering (Details) [Line Items]
Exercises price per share	$ 11.5	$ 11.5	$ 11.5

Private Placement (Details)

Private Placement (Details) - Private Placement [Member]	9 Months Ended
Private Placement (Details) - Private Placement [Member]	Sep. 30, 2023 USD ($) $ / shares shares
Private Placement [Line Items]
Aggregate of purchase price shares \| shares	1,003,000
Purchase price per shares \| $ / shares	$ 10
Aggregate of purchase price \| $	$ 10,030,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

Aug. 07, 2023

Feb. 10, 2021

Mar. 25, 2022

Feb. 28, 2021

Aug. 26, 2020

Sep. 30, 2023

Sep. 30, 2022

Jun. 30, 2023

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Jan. 11, 2023

Related Party Transactions (Details) [Line Items]

Aggregate purchase price

$ 49,880

Restrictions on transfer period of time after business combination completion

1 year

Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination

30 days

Shares, issued (in Shares)

40,302,259

Business combination converted

$ 1,500,000

Changes in fair value

803,000

$ 475,000

Expenses incurred and paid

$ 235,945

$ 215,357

$ 657,639

$ 827,471

Share price per unit (in Dollars per share)

$ 10.12841302

Sponsor [Member]

Related Party Transactions (Details) [Line Items]

Due to the affiliate

$ 70,000

Initial Public Offering [Member]

Related Party Transactions (Details) [Line Items]

Cover loan expenses

$ 1,500,000

Class B Common Stock [Member]

Related Party Transactions (Details) [Line Items]

Common Stock, Shares, Outstanding (in Shares)

10,350,000

Class B Common Stock [Member] | Founders Shares [Member]

Related Party Transactions (Details) [Line Items]

Aggregate purchase price

$ 25,000

Class A Common Stock [Member]

Related Party Transactions (Details) [Line Items]

Common Stock, Shares, Outstanding (in Shares)

11,352,999

1,003,000

Shares, issued (in Shares)

10,349,999

Class A Common Stock [Member] | Founders Shares [Member]

Related Party Transactions (Details) [Line Items]

Shares, issued (in Shares)

10,349,999

Class A Common Stock [Member] | Sponsor [Member]

Related Party Transactions (Details) [Line Items]

Issued and outstanding shares

94.90%

Chief Executive Officer [Member] | Initial Public Offering [Member]

Related Party Transactions (Details) [Line Items]

Aggregate of founder shares (in Shares)

100,000

Aggregate purchase price

$ 1,000,000

Share price per unit (in Dollars per share)

$ 10

Related Party [Member]

Related Party Transactions (Details) [Line Items]

Promissory note

$ 803,000

$ 475,000

Business Combination [Member]

Related Party Transactions (Details) [Line Items]

Business combination share price (in Dollars per share)

$ 10

Founders Shares [Member]

Related Party Transactions (Details) [Line Items]

Stock dividend per share (in Dollars per share)

$ 0.2

Shares subject to forfeiture (in Shares)

1,350,000

Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders

20%

Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination

20 days

Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences

150 years

Founders Shares [Member] | Over-Allotment Option [Member]

Related Party Transactions (Details) [Line Items]

Purchase share (in Shares)

5,400,000

Unit price (in Dollars per share)

$ 10

Founders Shares [Member] | Class B Common Stock [Member]

Related Party Transactions (Details) [Line Items]

Aggregate of founder shares (in Shares)

8,625,000

Common Stock, Shares, Outstanding (in Shares)

10,350,000

Founders Shares [Member] | Class A Common Stock [Member]

Related Party Transactions (Details) [Line Items]

Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in Dollars per share)

$ 12

Administrative Support Agreement [Member]

Related Party Transactions (Details) [Line Items]

Expenses per month

$ 10,000

Expenses incurred and paid

30,000

$ 30,000

Advisory Agreement [Member]

Related Party Transactions (Details) [Line Items]

Expenses incurred and paid

$ 60,000

Due to the affiliate

$ 140,000

Advisory Agreement [Member] | Chief Executive Officer [Member]

Related Party Transactions (Details) [Line Items]

Advisor fees

$ 20,000

Commitments (Details)

Commitments (Details) - USD ($)		9 Months Ended
Commitments (Details) - USD ($)	Feb. 10, 2021	Sep. 30, 2023
Commitments [Line Items]
Additional units		486,584
Cash underwriting discount rate		3.50%
Gross proceeds		$ 14,490,000
Over-Allotment Option [Member]
Commitments [Line Items]
Additional units	5,400,000
Initial Public Offering [Member]
Commitments [Line Items]
Cash underwriting discount rate		2%
Gross proceeds	$ 414,000,000	$ 8,280,000

Warrants (Details)

Warrants (Details) - USD ($)		9 Months Ended
Warrants (Details) - USD ($)	Feb. 04, 2021	Sep. 30, 2023	Dec. 31, 2022
Warrants (Details) [Line Items]
Public warrants expire		5 years
Market value		$ 9.2
Percentage of market value		180%
Redemption trigger price		$ 10
Consideration receivable percentage	70%
Fair value (in Dollars)		$ 803,000	$ 475,000
Public Warrants [Member]
Warrants (Details) [Line Items]
Class of warrants or rights redemption price per share		$ 0.01
Newly adjusted issue share price		$ 18
Trading days		30 days
Percentage of market value		115%
Redemption trigger price		$ 18
Warrants price		$ 0.1
Warrants outstanding (in Shares)		8,280,000	8,280,000
Private Placement Warrants [Member]
Warrants (Details) [Line Items]
Warrants outstanding (in Shares)		200,600	200,600
Fair value (in Dollars)		$ 579,600	$ 16,480
Private Placement Warrants One [Member]
Warrants (Details) [Line Items]
Fair value (in Dollars)		$ 662,400	$ 18,540
Class A Common Stock [Member]
Warrants (Details) [Line Items]
Number of trading days		20 days
Trading days		30 days
Effective issue price		$ 9.2
Equity interest percentage		60%
Class A Common Stock [Member] \| Private Placement [Member]
Warrants (Details) [Line Items]
Trading days		30 days
Warrant Redemption [Member] \| Class A Common Stock [Member] \| Public Warrants [Member]
Warrants (Details) [Line Items]
Class of warrants or rights redemption price per share		$ 0.1
Newly adjusted issue share price		$ 10
Number of trading days		20 days
Trading days		30 days
Class of warrant or right period of notice prior to redemption		30 days
Public Warrants [Member] \| Class A Common Stock [Member]
Warrants (Details) [Line Items]
Newly adjusted issue share price		$ 18
Number of trading days		20 days
Warrant [Member] \| Public Warrants [Member]
Warrants (Details) [Line Items]
Warrants outstanding (in Shares)		8,280,000
Warrant [Member] \| Private Placement Warrants [Member]
Warrants (Details) [Line Items]
Warrants outstanding (in Shares)		200,600

Stockholders_ Equity (Deficit)

Stockholders’ Equity (Deficit) (Details) - USD ($)			9 Months Ended
Stockholders’ Equity (Deficit) (Details) - USD ($)	Aug. 07, 2023	Aug. 07, 2023	Sep. 30, 2023	Dec. 31, 2022	Feb. 04, 2021
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred shares authorized			1,000,000	1,000,000
Preferred shares, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Preferred stock, outstanding
Shares subject to possible redemption value (in Dollars)				$ 1,097,741
Stockholders exercised redeem shares			40,302,259
Temporary equity redemption shares			486,584
Aggregate redemption amount (in Dollars)			$ 5,000,000
Shares subject to possible redemption value			611,157	1,097,741
Common stock issued			486,584
Aggregate shares	10,349,999
Founder share conversion percentage	94.90%
Preferred Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Preferred stock issued
Preferred stock, outstanding
Class A Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock, shares authorized			200,000,000	200,000,000
Common stock, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Common stock outstanding			11,352,999	1,003,000
Stockholders exercised redeem shares		10,349,999
Redemption price per share (in Dollars per share)			$ 10.25
Common stock issued			11,352,999	1,003,000
Shares subject to possible redemption value			11,964,156
Common stock issued			486,584
Converted shares issued	10,349,999		11,964,156
Converted shares outstanding			302,023
Class B Common Stock [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock, shares authorized			20,000,000	20,000,000
Common stock, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Common stock outstanding			1	10,350,000
Common stock issued			1	10,350,000
Common stock, voting			one
Common stock issued					10,350,000
Common stock outstanding					10,350,000
Converted shares issued			1
Converted shares outstanding			1
Aggregate converted percentage				20%
Class B Common Stock [Member] \| Maximum [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock dividend			1.2
Class B Common Stock [Member] \| Minimum [Member]
Stockholders’ Equity (Deficit) (Details) [Line Items]
Common stock dividend			1

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended
	Feb. 10, 2021	Sep. 30, 2023
Fair Value Measurements [Abstract]
Fair value yield term		6 years 6 months
Exceeding redemption value per share (in Dollars per share)		$ 18
Price per warrant (in Dollars per share)	$ 1.57
Private placement warrants	$ 12,600
Public warrants	$ 31,600
Aggregate of public warrants		$ 1,020

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of Fair Value Liabilities - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Level 1 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash and marketable securities held in Trust Account	$ 6,306,990	$ 12,263,483
Public Warrants	579,600	662,400
Level 2 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Private Placement Warrants	16,480	18,540
Level 3 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Promissory Note payable – related party, at fair value	$ 803,000	$ 475,000

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of the Monte Carlo Simulation Model for the Private Placement Warrants and Public Warrants - $ / shares		9 Months Ended
	Feb. 10, 2021	Sep. 30, 2023
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk-free interest rate		4.60%
Expected term (years)		5 years
Expected term to consummate the Business Combination (years)		3 months
Expected Volatility		25.70%
Exercise Price		$ 11.5
Stock price		$ 10.24
Private Placement Warrants and Public Warrants [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk-free interest rate	74%
Expected term to consummate the Business Combination (years)	6 years 6 months
Expected Volatility	15%
Exercise Price	$ 11.5
Stock price	$ 9.8

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Warrant Liabilities	9 Months Ended
	Sep. 30, 2023 USD ($)
Private Placement Warrants [Member]
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Warrant Liabilities [Line Items]
Fair value as of beginning balance	$ 18,540
Change in valuation inputs or other assumptions	(2,060)	[1]
Fair value as of ending balance	16,480
Public Warrants [Member]
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Warrant Liabilities [Line Items]
Fair value as of beginning balance	662,400
Change in valuation inputs or other assumptions	(82,800)	[1]
Fair value as of ending balance	579,600
Warrant Liabilities [Member]
Fair Value Measurements (Details) - Schedule of Changes in the Fair Value of Warrant Liabilities [Line Items]
Fair value as of beginning balance	680,940
Change in valuation inputs or other assumptions	(84,860)	[1]
Fair value as of ending balance	$ 596,080

[1] Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the accompanying unaudited condensed statements of operations.

Fair Value Measurements (Deta_5

Fair Value Measurements (Details) - Schedule of Changes in Fair Value of the Level 3 Promissory Note- Related Party	9 Months Ended
	Sep. 30, 2023 USD ($)
Schedule of Changes in Fair Value of the Level3 Promissory Note Related Party [Abstract]
Fair value as of beginning balance	$ 475,000
Repayment of Promissory Note - Related Party	(50,000)
Advances on Promissory Note – Related Party	378,000
Change in fair value
Fair value as of ending balance	$ 803,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	9 Months Ended
Income Taxes (Details) - USD ($)	Sep. 30, 2023	Sep. 30, 2022
Income Taxes [Abstract]
Net operating loss carryovers	$ 0	$ 0
Valuation allowance increased	$ 128,364

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of Company’s Net Deferred Tax Assets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Schedule of Company’s Net Deferred Tax Assets [Abstract]
Organizational costs/Startup expenses	$ 568,395	$ 386,136
Total deferred tax asset	568,395	386,136
Valuation allowance	(568,395)	(386,136)
Deferred tax asset, net of allowance